<DOC>
	<DOCNO>NCT01414751</DOCNO>
	<brief_summary>Few study explore specific format effectiveness information effect real patient ' decision . We know little kind format would optimal help patient make well-informed real-life decision correspond preference . The trial develop clinical randomise design study risk communication share decision make general practitioner ( GP ) patient primary prevention cholesterol lower drug . Endpoints effect GPs ' information treatment effectiveness patient ' value patient ' tendency accept adhere treatment well feel content choice make . GPs randomise inform risk treatment effectiveness mean either absolute risk reduction ( ARR ) Prolongation Life ( POL ) . Afterwards patient invite answer questionnaire concern content decision reflection . Patients ' redemption prescription follow week first year record electronic database . 57 GPs 248 patient enrolled trial .</brief_summary>
	<brief_title>Influence Intervention Methodologies Patient Choice Therapy</brief_title>
	<detailed_description>As chronic disease steadily increase industrialized country , grow focus preventive initiative . This mean risk communication physician patient plays central role . Effective risk communication enhance knowledge , involvement decision test treatment , autonomy empowerment patient . Poor communication , however , lead anxiety , lack confidence health care professional , adverse outcomes . It vital identify available evidence best do . The standard format use communicate intervention effectiveness absolute risk reduction , relative risk reduction , number need treat , life prolongation life . Few study explore format ' influence real patient decision , imply know little kind format would optimal help patient make well-informed real-life decision correspond preference . In clinical randomized design risk communication study preventive talk general practitioner ( GP ) patient concern cardiovascular disease . Special focus influence information format patient ' choice therapy , adherence therapy satisfaction therapy . GPs randomize one two group , teach inform patient mean either absolute risk reduction , ARR life extension , LE . The set preventive talk GP 's clinic . From measure total-cholesterol GP inform patient individual risk get cardiovascular disease possible effectiveness cholesterol-lowering drug . This do mean either ARR LE . After talk patient invite answer questionnaire concern personal experience information give ( deadline 2 week talk ) , 3 month receive questionnaire concern satisfaction decision make reflection . Patients ' redemption prescription follow week first year record Odense PharmacoEpidemiological Database , OPED . The GPs ' opinion , experience concern risk communication , prevention , usage statin explore mean questionnaire .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>4069 yearolds Patients measure totalcholesterol &gt; 4 MMol/Litre Patients diabetes Patients know chronic cardiovascular disease Patients already treat cholesterol lower therapy Patients familiar danish language</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Risk communication</keyword>
	<keyword>Shared decision making</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Prevention</keyword>
</DOC>